Business Arrowhead Pharmaceuticals prices $625 million convertible notes offering Published 2 days ago on 8 January 2026 By NewsAdmin Arrowhead Pharmaceuticals prices $625 million convertible notes offering Source link Related Topics: Up Next Trump blocks defense company stock buybacks until performance improves Don't Miss Government offers to intervene in row with unions Continue Reading Advertisement You may like Click to comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.